Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

GRF Eagle Capital Growth Fund Inc

9,20

-0,50 (-5,15%)

10 Apr 2025 - Geschlossen

Verzögert um 15 Minuten

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Eagle Capital Growth (AMEX:GRF)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Eagle Capital Growth Charts.

Eagle Capital Growth (AMEX:GRF)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Eagle Capital Growth Charts.

News Eagle Capital Growth Fund Inc

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)
Donnerstag 10 April 2025 (9 Stunden vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Donnerstag 6 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form N-CSR - Certified Shareholder Report
Donnerstag 6 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)
Freitag 28 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form N-CEN - Annual Report for Registered Investment Companies
Freitag 28 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
Dienstag 14 Januar 2025 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 5 Dezember 2024 (4 Monate vor) • Edgar (US Regulatory)

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Dienstag 19 November 2024 (5 Monate vor) • GlobeNewswire Inc.

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash
Montag 18 November 2024 (5 Monate vor) • Business Wire

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Dienstag 29 Oktober 2024 (5 Monate vor) • GlobeNewswire Inc.

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
Dienstag 22 Oktober 2024 (6 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 3 Oktober 2024 (6 Monate vor) • Edgar (US Regulatory)

Weitere Eagle Capital Growth Fund Inc News-Artikel

Financial Select Sector

Deutsche Telekom (QX)

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen